Europe’s pharma titans confront von der Leyen with threat to yank $113 billion from EU and relocate to U.S. as Trump plans ’major’ tariffs9 April 2025
Billionaire Harvard Professor’s Fortune Jumps Nearly $200 Million On News Of Eli Lilly Biotech DealBy Press Room8 July 2024 Harvard professor Timothy Springer first made headlines in 2020 when a biotech company he had invested in—Moderna—suddenly became a household…